Pacific Edge Limited

ASX:PEB

Pacific Edge Limited

ASX:PEB
TradeAdd trade order Follow Unfollow Set Price Alert
$0.100 (-4.8%)
Last close price
#263
Rank
1
Held by
1
Followers
TradeAdd trade order Follow Unfollow Set Price Alert
Reports My Report Forum Investors
Top member reports
Consensus
Scoonie
Company Report
Last edited 2 months ago
PerformanceCommunity EngagementCommunity Endorsement
ranked
#20
Performance (25m)
31.1% pa
Followed by
82
Follow Unfollow
Straws
Sort by:
Recent
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
Become a member
#Cancer Scare
Scoonie
Added 2 months ago
View author's company report

Yesterday PEB, the NZ headquartered and ASX listed company announced:

“Cancer diagnostics company Pacific Edge (NZX, ASX: PEB) today notes that Novitas, the Medicare Administrative Contractor with jurisdiction for our US laboratory, on Thursday 9 January 2025 finalized a non-coverage determination that would end reimbursement for Cxbladder Triage, Detect and Monitor by Medicare”.

With the already sick PEB share price approaching stage IV terminal, on yesterdays news PEB dropped a further 60%.  Looks like PEB joins RHY (bowel cancer diagnosis), BDX (breast cancer diagnosis) and PIQ (Diabetic Kidney disease and endometriosis) as a full blown ASX Cancer Cluster. 

Sadly for everyone, no cure in sight.